Universal Health Realty Income Trust (UHT) AI Stock Analysis

Universal Health Realty Income Trust is a real estate investment trust specializing in healthcare and human service-related facilities across the United States. Its portfolio includes acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical and office buildings, free-standing emergency departments, and childcare centers. The trust holds investments across multiple states providing essential healthcare infrastructure, and also undertakes ongoing development projects. Headquartered in the United States, the trust focuses on healthcare real estate asset management to support healthcare providers nationwide.

Revenue grew from $84.2M in FY2021 to $90.6M in FY2022, $95.6M in FY2023, $99.0M in FY2024, and $99.2M in FY2025, reflecting a 5-year revenue CAGR of 4.9%. Gross margin remained consistent, recording 94.4% in FY2025 compared to 94.8% in FY2021. Operating margin was 35.0% in FY2025, while net income stood at $17.6M with EPS of $1.27, down from $109.2M and EPS of $7.93 in FY2021. For the trailing twelve months ending June 30, 2026, revenue reached $101.2M with a profit margin of 19.1%. In the latest quarter, quarterly revenue growth was 0.7% year-over-year while quarterly earnings growth increased 33.4%.

As of June 30, 2026, Universal Health Realty Income Trust held $6.8M in cash and short-term investments alongside total debt of $395.1M, resulting in net debt of $388.3M. Shareholders' equity was $143.9M, producing a debt-to-equity ratio of 2.75 and a current ratio of 0.05. In FY2025, operating cash flow and free cash flow both totaled $49.1M. Cash uses in FY2025 included $8.8M for capital expenditures and $41.0M paid in dividends, while share issuance generated $156,000.

Universal Health Realty Income Trust trades at a trailing P/E of 27.4x and a forward P/E of 38.8x, both above the US-listed Real Estate peer median trailing P/E of 21.6x and forward P/E of 23.5x. Its price-to-sales multiple is 5.2x compared to the peer median of 3.7x, while its EV-to-EBITDA stands at 13.6x versus the peer median of 14.7x. Over the past year, the stock returned 14.5%, trailing the S&P 500 return of 16.8%. Over a 5-year period, the stock declined 6.8% compared to an 83.0% gain for the S&P 500.

The trust pays a quarterly dividend with an annualized forward dividend of $3.00, representing a dividend yield of 7.86%. It has maintained 40 consecutive years of dividend payments with a 5-year annualized dividend growth rate of 1.4%. Its payout ratio is 1.6%, and the last ex-dividend date was September 21, 2026.

Wall Street coverage consists of 1 Hold rating, with 0 Strong Buy, 0 Buy, 0 Sell, and 0 Strong Sell ratings. The mean price target is $44.00, representing upside of 15.3% from the last close of $38.15. Revenue is estimated at $99.5M for the current fiscal year ending December 31, 2026, and $104.7M for the next fiscal year, representing expected revenue growth of 5.2%. The trust's next earnings date is October 26, 2026.

This page is an AI-written research summary of Universal Health Realty Income Trust (UHT). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: UHT income statement, UHT balance sheet, UHT key metrics, UHT analyst forecast, UHT chart. See the UHT stock overview for the latest quote and news.